Brain fog may signal psychosis risk, new study suggests
NCT ID NCT06539611
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 125 young people (ages 15–30) who are at risk for developing psychosis. Researchers want to see if a person's own complaints about thinking and memory problems can help predict whether they will later develop full psychosis. Participants are assessed over 30 months using interviews and questionnaires. The goal is to better understand early warning signs, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 125 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Mar 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All youth help-seekers assessed by early intervention team meeting the inclusion criteria will be asked to participate to the study.
- Ages
-
15 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female ; * Be aged between 15 and 30 ; * Being assessed by the eDIP (early intervention team "équipe de détection et d'intervention précoce") ; * Sufficient level of French to understand and express yourself orally and in writing; * For adults: Patients who have received informed information about the study and who have signed a consent to participate in the study; \- For minors: Patient who has received informed information about the study and who has signed, as well as the holders of parental authority the minor's consent to participate in the study. Exclusion Criteria: * Have already presented a First Psychotic Episode; * Previous diagnosis of schizophrenia, psychotic disorder or bipolar disorder; * Being on antipsychotic treatment at the time of inclusion ; * Known intellectual disability ; * Pregnant or breast-feeding woman; * Minors and adults under legal protection.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for At-risk mental states are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mirvat B HAMDAN-DUMONT
Limoges, 87025, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.